Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) EPS (Basic) (2016 - 2025)

Mimedx's EPS (Basic) history spans 15 years, with the latest figure at $0.11 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 120.0% year-over-year to $0.11; the TTM value through Dec 2025 reached $0.33, up 13.79%, while the annual FY2025 figure was $0.33, 13.79% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.11 at Mimedx, roughly flat from $0.11 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.4 in Q4 2023 and bottomed at -$0.11 in Q1 2022.
  • The 5-year median for EPS (Basic) is $0.05 (2024), against an average of $0.03.
  • The largest annual shift saw EPS (Basic) tumbled 266.67% in 2022 before it soared 2100.0% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.02 in 2021, then changed by 0.0% to -$0.02 in 2022, then skyrocketed by 2100.0% to $0.4 in 2023, then tumbled by 87.5% to $0.05 in 2024, then surged by 120.0% to $0.11 in 2025.
  • Per Business Quant, the three most recent readings for MDXG's EPS (Basic) are $0.11 (Q4 2025), $0.11 (Q3 2025), and $0.06 (Q2 2025).